Company: TGNT
Filing Date: 2025-04-30
Form Type: S-1
Source: 0001477932-25-003124
Chunk: 3

Company: Totaligent, Inc.
Filing Date: 2025-04-30
Form: S-1
Chunk 3
---
 prospectus, or the perception that these sales could occur, could result in a decline in the public trading price of our common stock. We provide more information about how the Selling Stockholder may sell or otherwise dispose of the shares of our common stock in the section entitled “Plan of Distribution.” We will bear all costs, expenses, and fees in connection with the registration of the shares of common stock offered hereby. The Selling Stockholder will bear all commissions and discounts, if any, attributable to its sales of the shares of common stock offered hereby.

The Selling Stockholder is an “underwriter” within the meaning of Section 2(a)(11) of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and any profits on the sales of shares of our common stock by the Selling Stockholder and any discounts, commissions, or concessions received by the Selling Stockholder are deemed to be underwriting discounts and commissions under the Securities Act.

| 2 |

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

We are not currently a reporting company under Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as a result of our filing of a Form 15 on April 15, 2018 terminating our obligation to file reports. However, commencing with the filing on October 29, 2024 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, we have been voluntarily filing our Exchange Act reports. Our Common Stock is currently quoted on the OTC Pink Market under the symbol “TGNT.” As of April 29, 2025, the last reported sales price for our Common Stock as quoted on the OTC Pink Market was $0.01285 per share. Quotes of stock trading prices on an over-the-counter marketplace may not be indicative of the market price on a national securities exchange. There is a limited public trading market for our Common Stock.

Investing in our securities involves a high degree of risk. See “ Risk Factors” beginning on page 13 of this prospectus, as well as the other information contained in or incorporated by reference in this prospectus or in any accompanying prospectus supplement before making a decision to invest in our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved